Prenatal diagnosis: A connotation on genetic counseling being indispensable

被引:3
作者
Ramesh, Anuradha [1 ]
Parvathi, Venkatachalam Deepa [1 ]
机构
[1] Sri Ramachandra Inst Higher Educ & Res, Dept Human Genet, Chennai 600116, Tamil Nadu, India
关键词
Chromosomal anomalies; Down syndrome; genetic counseling; prenatal diagnosis; prenatal testing;
D O I
10.4103/ijph.IJPH_116_19
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Prenatal testing and diagnosis are gaining a strong foothold in a progressively developing country like India, and an estimated boom in the market of noninvasive prenatal testing is predicted by the year 2024. Having said this, every technique needs an adequate amount of supplementation to increase its worth and that is where genetic counseling proves to be indispensable. Postdiagnosis, the women classified as high-risk individuals likely to give birth to infants inflicted with congenital and structural anomalies are appropriately counseled regarding the clinical aspects of the disease, life expectancy associated with the same, and the consequences associated with the decision to go ahead and conceive the child. Genetic counseling is majorly done for Down syndrome as the other aneuploidies have a highly reduced life expectancy. Although there are a variety of techniques available for testing various chromosomal anomalies, information regarding the appropriate time of the test and emphasis on pre- and posttest counseling is usually not supplied to primary physicians. A considerable amount of confusion dominates the decision of which test should be employed for testing of which anomaly as an array of rather efficient techniques has been identified. Furthermore, there is no nation-wide consensus of the timing and nature of these screening protocols. Moreover, ambiguous guidelines along with an impending lacuna in terms of awareness have led to India being at the backseat of the era that has ushered in tons of technological advancement in this field.
引用
收藏
页码:83 / 85
页数:3
相关论文
共 10 条
  • [1] Gadhia Pankaj Gadhia Pankaj, 2015, British Journal of Medicine and Medical Research, V5, P1255, DOI 10.9734/BJMMR/2015/13648
  • [2] GARMEL SH, 1994, SEMIN PERINATOL, V18, P117
  • [3] Girisha KM, 2007, INDIAN PEDIATR, V44, P131
  • [4] Markov D, 2004, Akush Ginekol (Sofiia), V43, P3
  • [5] Prenatal screening for genetic disorders: Suggested guidelines for the Indian Scenario
    Phadke, Shubha R.
    Puri, Ratna D.
    Ranganath, Prajnya
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2017, 146 : 689 - 699
  • [6] Sharma D, 2017, IMP J INTERDISCIP RE, V3, P245
  • [7] First trimester maternal serum screening using biochemical markers PAPP-A and Free β-hCG for down syndrome, patau syndrome and edward syndrome
    Shiefa S.
    Amargandhi M.
    Bhupendra J.
    Moulali S.
    Kristine T.
    [J]. Indian Journal of Clinical Biochemistry, 2013, 28 (1) : 3 - 12
  • [8] Spencer K, 1996, PRENATAL DIAG, V16, P1101, DOI 10.1002/(SICI)1097-0223(199612)16:12<1101::AID-PD5>3.0.CO
  • [9] 2-7
  • [10] Zhong A, 2018, GENET MED, V9, P1